Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: summary of a 1999 symposium.
暂无分享,去创建一个
C P Price | R Haeckel | A. Wu | C. Price | K. Lewandrowski | R. Haeckel | J. Hicks | J M Hicks | K Lewandrowski | A H Wu | A. Wu
[1] W. Maughan,et al. Clinical outcomes of point-of-care testing in the interventional radiology and invasive cardiology setting. , 2000, Clinical chemistry.
[2] G J Kost,et al. Point-of-care glucose testing: effects of critical care variables, influence of reference instruments, and a modular glucose meter design. , 2000, Archives of pathology & laboratory medicine.
[3] C. Price,et al. Laboratory medicine in the United Kingdom: 1948-1998 and beyond. , 1999, Clinica chimica acta; international journal of clinical chemistry.
[4] D. Mutrie. A new chest pain strategy in Thunder Bay. , 1999, CJEM.
[5] G J Kost,et al. The laboratory-clinical interface: point-of-care testing. , 1999, Chest.
[6] I. Watson,et al. Point-of-care testing outcomes in an emergency department. , 1999, Clinical chemistry.
[7] M. Clancy,et al. The Portable Laboratory: An Evaluation of the Accuracy and Reproducibility of i-STAT© , 1999, Annals of clinical biochemistry.
[8] R. Califf,et al. Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. , 1998, American heart journal.
[9] S. Griffin,et al. Diabetes care in general practice: meta-analysis of randomised control trials. , 1998, BMJ.
[10] S J Steindel,et al. Evaluating stat testing options in an academic health center: therapeutic turnaround time and staff satisfaction. , 1998, Clinical chemistry.
[11] M. Clancy,et al. Point of care testing: randomised controlled trial of clinical outcome , 1998, BMJ.
[12] D. Fitzmaurice,et al. A review of near patient testing in primary care. , 1997, Health technology assessment.
[13] T. Zerbe,et al. Laboratory process improvement through point-of-care testing. , 1997, The Joint Commission journal on quality improvement.
[14] R. Jones,et al. An evaluation of near‐patient testing for Helicobacter pylori in general practice , 1997, Alimentary pharmacology & therapeutics.
[15] C A Parvin,et al. Impact of point-of-care testing on patients' length of stay in a large emergency department. , 1996, Clinical chemistry.
[16] J. Dunbar,et al. Evaluation of a primary care anticoagulant clinic managed by a pharmacist , 1996, BMJ.
[17] B. Bain,et al. Guide-lines for near patient testing: haematology. , 1995, Clinical and laboratory haematology.
[18] K. Lewandrowski,et al. Near patient blood glucose monitoring. , 1995, Archives of pathology & laboratory medicine.
[19] M Fleisher,et al. Automated approaches to rapid-response testing. A comparative evaluation of point-of-care and centralized laboratory testing. , 1995, American journal of clinical pathology.
[20] P. H. Petersen,et al. Desirable performance standards for imprecision and bias in alternate sites. The views of laboratory professionals. , 1995, Archives of pathology & laboratory medicine.
[21] R. Winkens,et al. The validity of urine examination for urinary tract infections in daily practice. , 1995, Family practice.
[22] A. Dixon,et al. Measuring the effects of imaging: an evaluative framework. , 1995, Clinical radiology.
[23] E. Spitznagel,et al. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. , 1995, The Journal of thoracic and cardiovascular surgery.
[24] M F Burritt,et al. Point-of-care testing. , 1995, Mayo Clinic proceedings.
[25] P. Auerbach,et al. Evaluation of a portable clinical blood analyzer in the emergency department. , 1995, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[26] J. Nosanchuk,et al. Cost analysis of point-of-care laboratory testing in a community hospital. , 1995, American journal of clinical pathology.
[27] G S Cembrowski,et al. Patient and physician analytic goals for self-monitoring blood glucose instruments. , 1994, American journal of clinical pathology.
[28] J W Winkelman,et al. The fiscal consequences of central vs distributed testing of glucose. , 1994, Clinical chemistry.
[29] J. Winkelman,et al. Quantification of medical and operational factors determining central versus satellite laboratory testing of blood gases. , 1994, American journal of clinical pathology.
[30] M. Berkus,et al. Intensified versus conventional management of gestational diabetes. , 1994, American journal of obstetrics and gynecology.
[31] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[32] B. Sibbald,et al. Impact of introducing near patient testing for standard investigations in general practice. , 1993, BMJ.
[33] M. Berkus,et al. Glucose Tolerance Test: Degree of Glucose Abnormality Correlates With Neonatal Outcome , 1993, Obstetrics and gynecology.
[34] C P Price,et al. Extra‐laboratory Blood Glucose Measurement: A Policy Statement , 1988, Diabetic medicine : a journal of the British Diabetic Association.
[35] T. Koschinsky,et al. New Approach to Technical and Clinical Evaluation of Devices for Self-Monitoring of Blood Glucose , 1988, Diabetes Care.
[36] D. Cox,et al. Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose , 1987, Diabetes Care.
[37] S. Kalhan,et al. Gestational Diabetes Mellitus: Is Further Improvement Necessary? , 1985, Diabetes.
[38] W. Oh,et al. Neonatal Morbidities in Infants of Mothers with Glucose Intolerance in Pregnancy , 1985, Diabetes.
[39] J. Skyler,et al. Self-monitoring of blood glucose. , 1982, The Medical clinics of North America.
[40] G J Kost,et al. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. , 2000, American journal of clinical pathology.
[41] P. Collinson,et al. The need for a point of care testing: an evidence-based appraisal. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[42] R. Hendel,et al. A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium Investigators. , 1999, American heart journal.
[43] C. Price. Point of Care Testing in Haematology. , 1998, Hematology.
[44] D. Benjamin. Editorial: Reengineering the Clinical Laboratory , 1997 .
[45] M. A. Smith,et al. Health technology assessment and the NHS R&D initiative. , 1996, Journal of medical engineering & technology.
[46] B. Kasiske,et al. Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[47] E. Spitznagel,et al. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. , 1994, The Journal of thoracic and cardiovascular surgery.
[48] J. Hall,et al. A ROLE FOR COMMUNITY PHARMACISTS IN THE CONTROL OF ANTICOAGULANT THERAPY , 1994 .
[49] R. M. Greendyke. Cost analysis. Bedside blood glucose testing. , 1992, American journal of clinical pathology.
[50] Rainer Haeckel,et al. Cost Implications of Decentralized Testing — A Laboratorian’s View , 1987 .
[51] J. Ashby. The Patient and Decentralized Testing , 1987 .
[52] C. Ward,et al. The Patient with Chest Pain , 1981 .